跳至主要内容
临床试验/IRCT20110310006026N13
IRCT20110310006026N13招募中Unknown

Evaluating the effectiveness and safety of rosemary (Rosmarinus officinalis L.) on cognitive impairments, and positive and negative symptoms in patients with chronic schizophrenia: double blind placebo-controlled randomized trial

Kerman University of Medical Sciences0 个研究点目标入组 50 人开始时间: 待定最近更新:
适应症

试验速览

阶段
Unknown
状态
招募中
入组人数
50

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 65 years(—)
性别
All

入选标准

  • Hospitalized patients with chronic schizophrenia (6 months or more should be passed from illness commencement) based on DSM-V criteria
  • Having no significant change in medication or symptoms over the previous 2 months

排除标准

  • Mental retardation
  • Substance dependence
  • History of significant medical illness
  • Alterations in the received medications
  • Hypersensitivity reactions to rosemary

研究者

相似试验